The effect of cholesterol-lowering therapy on the progression of diabetic nephropathy is unproved (Letter to the editor by R. Bender) Response Cholesterol lowering therapy reduces the rise in serum creatinine and urinary protein in NiDDM patients with nephropathy
differences in mean decrements in GFR were also not statistically significant.
A multicentre study involving a much larger number of patients will be required to demonstrate conclusively whether cholesterol lowering therapy does reduce the rate of progression of diabetic nephropathy. Table 1 ; * p < 0.005; 9 ** p < 0.001 vs control
